Nebenwirkungen neuer onkologischer Immuntherapien

Systemic treatment with immune checkpoint inhibitors (ICI) has revolutionized the treatment of hematological and oncological diseases in recent years. The mechanism of action hinges on enhancing the natural ability of the immune system to eliminate malignant cells. The most important substances in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, G. S., Kirschner, M., Rübben, A., Wahl, R. U., Amann, K., Benesova, K., Leipe, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2020
Materias:
CME
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189634/
https://www.ncbi.nlm.nih.gov/pubmed/32351619
http://dx.doi.org/10.1007/s11560-020-00424-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189634/
https://www.ncbi.nlm.nih.gov/pubmed/32351619
http://dx.doi.org/10.1007/s11560-020-00424-8

Ejemplares similares